Bo Cumbo, AavantiBio CEO (file photo)

Bo Cum­bo jumps from the top com­mer­cial post at Sarep­ta to the helm of a gene ther­a­py start­up with some in­flu­en­tial back­ers, big plans and $107M

Af­ter a 7-year stretch build­ing the com­mer­cial team at Sarep­ta, long­time drug sales­man Bo Cum­bo is jump­ing to the en­tre­pre­neur­ial side of the busi­ness, tak­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.